| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | GTPase activator activity | TBC1D3E TBC1D3 TBC1D3L TBC1D3H TBC1D3I TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 1.26e-11 | 279 | 43 | 11 | GO:0005096 |
| GeneOntologyMolecularFunction | enzyme activator activity | TBC1D3E TBC1D3 TBC1D3L TBC1D3H TBC1D3I TBC1D3D FYN TBC1D3G CTSH TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 6.81e-10 | 656 | 43 | 13 | GO:0008047 |
| GeneOntologyMolecularFunction | GTPase regulator activity | TBC1D3E TBC1D3 TBC1D3L TBC1D3H TBC1D3I TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 7.00e-09 | 507 | 43 | 11 | GO:0030695 |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | TBC1D3E TBC1D3 TBC1D3L TBC1D3H TBC1D3I TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 7.00e-09 | 507 | 43 | 11 | GO:0060589 |
| GeneOntologyMolecularFunction | molecular function activator activity | TBC1D3E ZNF106 TBC1D3 TBC1D3L TBC1D3H TBC1D3I TBC1D3D FYN TBC1D3G CTSH TBC1D3C TBC1D3B WNT16 TBC1D3K TBC1D3F | 1.95e-08 | 1233 | 43 | 15 | GO:0140677 |
| GeneOntologyMolecularFunction | enzyme regulator activity | TBC1D3E BCL2A1 TBC1D3 TBC1D3L TBC1D3H TBC1D3I TBC1D3D FYN TBC1D3G CTSH TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 8.61e-07 | 1418 | 43 | 14 | GO:0030234 |
| GeneOntologyMolecularFunction | antigen binding | 3.12e-06 | 190 | 43 | 6 | GO:0003823 | |
| GeneOntologyMolecularFunction | serine-type peptidase activity | 1.01e-03 | 207 | 43 | 4 | GO:0008236 | |
| GeneOntologyMolecularFunction | serine hydrolase activity | 1.10e-03 | 212 | 43 | 4 | GO:0017171 | |
| GeneOntologyMolecularFunction | scavenger receptor activity | 1.54e-03 | 27 | 43 | 2 | GO:0005044 | |
| GeneOntologyBiologicalProcess | activation of GTPase activity | TBC1D3E TBC1D3 TBC1D3L TBC1D3H TBC1D3I TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 2.67e-16 | 109 | 43 | 11 | GO:0090630 |
| GeneOntologyBiologicalProcess | positive regulation of hydrolase activity | TBC1D3E BCL2A1 TBC1D3 TBC1D3L TBC1D3H TBC1D3I TBC1D3D FYN TBC1D3G CTSH TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 8.10e-13 | 499 | 43 | 14 | GO:0051345 |
| GeneOntologyBiologicalProcess | positive regulation of GTPase activity | TBC1D3E TBC1D3 TBC1D3L TBC1D3H TBC1D3I TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 2.09e-12 | 244 | 43 | 11 | GO:0043547 |
| GeneOntologyBiologicalProcess | regulation of GTPase activity | TBC1D3E TBC1D3 TBC1D3L TBC1D3H TBC1D3I TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 6.37e-11 | 335 | 43 | 11 | GO:0043087 |
| GeneOntologyBiologicalProcess | regulation of hydrolase activity | TBC1D3E BCL2A1 TBC1D3 TBC1D3L TBC1D3H TBC1D3I TBC1D3D FYN TBC1D3G CTSH TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 1.43e-09 | 878 | 43 | 14 | GO:0051336 |
| GeneOntologyBiologicalProcess | positive regulation of catalytic activity | TBC1D3E BCL2A1 TBC1D3 TBC1D3L TBC1D3H TBC1D3I TBC1D3D FYN TBC1D3G CTSH TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 1.08e-08 | 1028 | 43 | 14 | GO:0043085 |
| GeneOntologyBiologicalProcess | positive regulation of molecular function | TBC1D3E BCL2A1 TBC1D3 TBC1D3L TBC1D3H TBC1D3I TBC1D3D FYN TBC1D3G CTSH TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 6.46e-07 | 1430 | 43 | 14 | GO:0044093 |
| GeneOntologyBiologicalProcess | immunoglobulin mediated immune response | 8.79e-06 | 235 | 43 | 6 | GO:0016064 | |
| GeneOntologyBiologicalProcess | B cell mediated immunity | 1.09e-05 | 244 | 43 | 6 | GO:0019724 | |
| GeneOntologyBiologicalProcess | lymphocyte mediated immunity | 3.62e-05 | 449 | 43 | 7 | GO:0002449 | |
| GeneOntologyBiologicalProcess | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 4.34e-05 | 462 | 43 | 7 | GO:0002460 | |
| GeneOntologyBiologicalProcess | immune effector process | IGHV7-4-1 LIPA FYN CTSH IGHV1-38-4 IGHV1-45 IGHV1-18 IGHV1-8 IGHV1-3 | 5.69e-05 | 859 | 43 | 9 | GO:0002252 |
| GeneOntologyBiologicalProcess | leukocyte mediated immunity | 1.72e-04 | 576 | 43 | 7 | GO:0002443 | |
| GeneOntologyBiologicalProcess | adaptive immune response | IGHV7-4-1 FYN CTSH IGHV1-38-4 IGHV1-45 IGHV1-18 IGHV1-8 IGHV1-3 | 2.94e-04 | 838 | 43 | 8 | GO:0002250 |
| GeneOntologyBiologicalProcess | protein processing | 3.05e-04 | 285 | 43 | 5 | GO:0016485 | |
| GeneOntologyBiologicalProcess | membrane protein proteolysis | 3.22e-04 | 64 | 43 | 3 | GO:0033619 | |
| GeneOntologyBiologicalProcess | peptide metabolic process | 7.15e-04 | 84 | 43 | 3 | GO:0006518 | |
| GeneOntologyCellularComponent | immunoglobulin complex | 1.09e-06 | 166 | 43 | 6 | GO:0019814 | |
| Domain | TBC | TBC1D3E TBC1D3L TBC1D3H TBC1D3I TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 1.92e-18 | 49 | 37 | 10 | SM00164 |
| Domain | RabGAP-TBC | TBC1D3E TBC1D3L TBC1D3H TBC1D3I TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 4.52e-18 | 53 | 37 | 10 | PF00566 |
| Domain | TBC_RABGAP | TBC1D3E TBC1D3L TBC1D3H TBC1D3I TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 6.76e-18 | 55 | 37 | 10 | PS50086 |
| Domain | Rab-GTPase-TBC_dom | TBC1D3E TBC1D3L TBC1D3H TBC1D3I TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 6.76e-18 | 55 | 37 | 10 | IPR000195 |
| Domain | ZP_dom_CS | 1.70e-04 | 10 | 37 | 2 | IPR017977 | |
| Domain | ZP_1 | 3.42e-04 | 14 | 37 | 2 | PS00682 | |
| Domain | ZP_2 | 3.42e-04 | 14 | 37 | 2 | PS51034 | |
| Domain | ZP | 3.95e-04 | 15 | 37 | 2 | SM00241 | |
| Domain | ZP_dom | 5.10e-04 | 17 | 37 | 2 | IPR001507 | |
| Domain | Zona_pellucida | 5.10e-04 | 17 | 37 | 2 | PF00100 | |
| Domain | SRCR | 7.83e-04 | 21 | 37 | 2 | PF00530 | |
| Domain | SR | 1.11e-03 | 25 | 37 | 2 | SM00202 | |
| Domain | - | 1.11e-03 | 25 | 37 | 2 | 3.10.250.10 | |
| Domain | SRCR_1 | 1.20e-03 | 26 | 37 | 2 | PS00420 | |
| Domain | SRCR-like_dom | 1.20e-03 | 26 | 37 | 2 | IPR017448 | |
| Domain | SRCR_2 | 1.20e-03 | 26 | 37 | 2 | PS50287 | |
| Domain | SRCR | 1.30e-03 | 27 | 37 | 2 | IPR001190 | |
| Domain | UBA-like | 7.13e-03 | 64 | 37 | 2 | IPR009060 | |
| Domain | Prot-tyrosine_phosphatase-like | 1.64e-02 | 99 | 37 | 2 | IPR029021 | |
| Pathway | WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME | TBC1D3E TBC1D3 TBC1D3L TBC1D3H TBC1D3I TBC1D3G TBC1D3C TBC1D3B TBC1D3K | 2.56e-13 | 99 | 29 | 9 | M46448 |
| Pubmed | TBC1D3, a hominoid oncoprotein, is encoded by a cluster of paralogues located on chromosome 17q12. | TBC1D3E TBC1D3 TBC1D3L TBC1D3H TBC1D3I TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 5.92e-33 | 11 | 46 | 11 | 16863688 |
| Pubmed | DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage. | 7.39e-12 | 74 | 46 | 7 | 16625196 | |
| Pubmed | 8.65e-09 | 4 | 46 | 3 | 8406013 | ||
| Pubmed | PRC17, a novel oncogene encoding a Rab GTPase-activating protein, is amplified in prostate cancer. | 8.65e-09 | 4 | 46 | 3 | 12359748 | |
| Pubmed | 2.16e-08 | 5 | 46 | 3 | 12604796 | ||
| Pubmed | 2.16e-08 | 5 | 46 | 3 | 8471161 | ||
| Pubmed | Developmentally controlled and tissue-specific expression of unrearranged VH gene segments. | 1.81e-07 | 9 | 46 | 3 | 2578321 | |
| Pubmed | Germline diversity of the expressed BALB/c VhJ558 gene family. | 1.81e-07 | 9 | 46 | 3 | 11483206 | |
| Pubmed | 1.81e-07 | 9 | 46 | 3 | 6789211 | ||
| Pubmed | 2.58e-07 | 10 | 46 | 3 | 3211160 | ||
| Pubmed | 1.74e-06 | 18 | 46 | 3 | 6788376 | ||
| Pubmed | Diversity of human copy number variation and multicopy genes. | 5.13e-06 | 3 | 46 | 2 | 21030649 | |
| Pubmed | 2.56e-05 | 6 | 46 | 2 | 9507006 | ||
| Pubmed | BANK1 and BLK act through phospholipase C gamma 2 in B-cell signaling. | 6.12e-05 | 9 | 46 | 2 | 23555801 | |
| Pubmed | IMGT/GENE-DB: a comprehensive database for human and mouse immunoglobulin and T cell receptor genes. | 1.48e-04 | 77 | 46 | 3 | 15608191 | |
| Pubmed | GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. | 8.28e-04 | 32 | 46 | 2 | 23535730 | |
| Pubmed | 1.17e-03 | 38 | 46 | 2 | 28680062 | ||
| Pubmed | 1.23e-03 | 39 | 46 | 2 | 8490662 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q12 | TBC1D3E TBC1D3 TBC1D3L TBC1D3H TBC1D3I TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 3.50e-18 | 149 | 46 | 11 | chr17q12 |
| Cytoband | 14q32.33 | IGHV7-4-1 IGHV1-38-4 IGHV1-45 IGHV1-18 IGHV1-8 IGHV1-3 IGHV1-2 | 3.08e-09 | 228 | 46 | 7 | 14q32.33 |
| Cytoband | 17q12 | 5.38e-08 | 99 | 46 | 5 | 17q12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr14q32 | 2.53e-04 | 566 | 46 | 5 | chr14q32 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q25 | 5.65e-04 | 160 | 46 | 3 | chr15q25 | |
| GeneFamily | Immunoglobulin heavy locus at 14q32.33 | IGHV7-4-1 IGHV1-38-4 IGHV1-45 IGHV1-18 IGHV1-8 IGHV1-3 IGHV1-2 | 8.44e-09 | 187 | 27 | 7 | 349 |
| GeneFamily | Endogenous ligands|Minor histocompatibility antigens | 2.62e-03 | 51 | 27 | 2 | 870 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_3 | 7.98e-06 | 25 | 41 | 3 | MM870 | |
| CoexpressionAtlas | Mesoderm Day 15_vs_Mesoderm Day 30-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3L TBC1D3H TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 7.19e-14 | 90 | 40 | 9 | PCBC_ratio_MESO-15_vs_MESO-30_cfr-2X-p05 |
| CoexpressionAtlas | Endoderm Differentiated Cells-reprogram_OSKM-L_vs_Endoderm Differentiated Cells-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3L TBC1D3H TBC1D3D TBC1D3G CTSH TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 5.44e-12 | 213 | 40 | 10 | PCBC_ratio_DE_from-OSKM-L_vs_DE_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Endoderm Differentiated Cells-method_mRNA_vs_Endoderm Differentiated Cells-method_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3L TBC1D3H TBC1D3D TBC1D3G CTSH TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 5.44e-12 | 213 | 40 | 10 | PCBC_ratio_DE_from-mRNA_vs_DE_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3L TBC1D3H TBC1D3D DNAJC6 TBC1D3G CTSH TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 1.20e-11 | 320 | 40 | 11 | PCBC_ratio_MESO-5_vs_DE_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5-reprogram_OSKM-L_vs_Mesoderm Day 5-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3L TBC1D3H TBC1D3D TBC1D3G CTSH TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 8.39e-11 | 281 | 40 | 10 | PCBC_ratio_MESO-5_from-OSKM-L_vs_MESO-5_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5-method_mRNA_vs_Mesoderm Day 5-method_NA-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3L TBC1D3H TBC1D3D TBC1D3G CTSH TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 8.39e-11 | 281 | 40 | 10 | PCBC_ratio_MESO-5_from-mRNA_vs_MESO-5_from-ESC_cfr-2X-p05 |
| CoexpressionAtlas | DE cord blood_vs_DE blastocyst-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3L TBC1D3H TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 5.62e-10 | 242 | 40 | 9 | PCBC_ratio_DE cord blood_vs_DE blastocyst_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 15_vs_Mesoderm Day 5-Confounder_removed-fold2.0_adjp0.05 | SPATA20 LIPA TBC1D3 TBC1D3L TBC1D3H TBC1D3D TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 2.50e-06 | 1049 | 40 | 11 | PCBC_ratio_MESO-15_vs_MESO-5_cfr-2X-p05 |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3L TBC1D3H TBC1D3D PNISR TBC1D3G TBC1D3C PTGIS TBC1D3B TBC1D3K TBC1D3F | 3.17e-06 | 1075 | 40 | 11 | PCBC_ratio_ECTO_vs_DE_cfr-2X-p05 |
| CoexpressionAtlas | Mesoderm Day 5_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3L TBC1D3H TBC1D3D DNAJC6 TBC1D3G CTSH TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 6.21e-06 | 1153 | 40 | 11 | PCBC_ratio_MESO-5_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | TBC1D3 TBC1D3L TBC1D3H TBC1D3D PNISR TBC1D3G TBC1D3C TBC1D3B TBC1D3K TBC1D3F | 2.98e-04 | 1466 | 40 | 10 | PCBC_ratio_ECTO_vs_SC_cfr-2X-p05 |
| ToppCell | severe-Myeloid-CD14_Monocytes_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.75e-06 | 200 | 45 | 5 | 2f1218c9884fabae952cdbff25b6baa7bae9e732 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_B_plasma-Plasma_cells|Lung / Manually curated celltypes from each tissue | 2.26e-05 | 164 | 45 | 4 | 3b6a32ba53d05f6818fe950ac426f489383b645a | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Nonclassical_Monocyte|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.46e-05 | 183 | 45 | 4 | 36b194e366a14ebc4df187bf31c902be3797bfcc | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Dendritic-conventional_dendritic_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.85e-05 | 188 | 45 | 4 | e35104ca327c2d9eb6ffed658051f62f855a0a0e | |
| ToppCell | wk_20-22-Hematologic-Myeloid-APOE+_Mac2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.93e-05 | 189 | 45 | 4 | e189ef6066f87177d758f0e3ed9a17e01031a391 | |
| ToppCell | control-Myeloid-CD14_Monocytes_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.93e-05 | 189 | 45 | 4 | 7f78b5bb8195f99b18082cbb612e9199b7a1538c | |
| ToppCell | control-Myeloid-CD14_Monocytes_2|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.01e-05 | 190 | 45 | 4 | 47513757e0059e8370e49672a577f25ca842e98c | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.01e-05 | 190 | 45 | 4 | 79ee6d10dfbb775da149a1104da5823cf63bbb46 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Plasma_cells-IgA_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.01e-05 | 190 | 45 | 4 | 18762ce78ed0b206ade19e1c8ff76a2647489f68 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.09e-05 | 191 | 45 | 4 | 5c0c44612b4cdbf89c0f1f219416374a7541f610 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.09e-05 | 191 | 45 | 4 | d1d30279ed4612b4f62c225d9eabf0b8a7a09d11 | |
| ToppCell | Tracheal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.35e-05 | 194 | 45 | 4 | a4a70369541876e1192df8828b63e3d1746ae3d9 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Macrophage-macrophage,_alveolar-Macro_c3-EREG|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.53e-05 | 196 | 45 | 4 | 80264c2fbd94418f981085fed7c5bdda1e6f404c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.53e-05 | 196 | 45 | 4 | 939c0d835e9700ac61df60884d3d86053b296410 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar-Macro_c3-EREG|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.62e-05 | 197 | 45 | 4 | 7293587c875738c1711b8a68d40303a197b01c32 | |
| ToppCell | 5'-Airway_Nasal-Immune_Lymphocytic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.62e-05 | 197 | 45 | 4 | 40b752b019c95994323c7f65644a6ccf336d327e | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.62e-05 | 197 | 45 | 4 | 989eaf7ecef8683e3ec6ec024fd193a2f5861b26 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.62e-05 | 197 | 45 | 4 | 2e622d75fb45cfa80f78e1880ad056a50709895a | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.62e-05 | 197 | 45 | 4 | b4869013f0523ac73c284e6cdaf64e9ae5213dc5 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.62e-05 | 197 | 45 | 4 | 82072bd73634e1ef24dc193e860af7786727313b | |
| ToppCell | severe|World / disease stage, cell group and cell class | 4.62e-05 | 197 | 45 | 4 | db7367210b5480b53002407f3e66988e85a5c22f | |
| ToppCell | myeloid-Monocyte-CD14+_Monocyte|World / Lineage, cell class and subclass | 4.71e-05 | 198 | 45 | 4 | 2528062d1646746b2e7d6b0ec38f8cfabf3df18f | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.71e-05 | 198 | 45 | 4 | 885cbd3695b466a161cf318d35ebbdfcc0c19cec | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.71e-05 | 198 | 45 | 4 | eb0a94c426a7c567f94490b848e28784587c6dcd | |
| ToppCell | 367C-Myeloid-Macrophage-SPP1+_Macrophage|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.71e-05 | 198 | 45 | 4 | 1771c282cd6422c35a4131c827d7daedfd6e7541 | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_monocytic-monocyte-CD14_monocyte|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.80e-05 | 199 | 45 | 4 | 50a30d5ee99e51743a0dd60144fc341ff68da9af | |
| ToppCell | Healthy_Control-Myeloid|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 4.80e-05 | 199 | 45 | 4 | 2b933b8dbc7c052eabc0c17d056c5a2b230e2e9a | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.80e-05 | 199 | 45 | 4 | b3974190972f173ed331c2242baf583fa3323657 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.80e-05 | 199 | 45 | 4 | 7504835a0849a7074d19d6cf7e3ec61586c85fdf | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-Myeloid|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.80e-05 | 199 | 45 | 4 | 41d240d44bd6cc301a7879cacee104c874b4ba2c | |
| ToppCell | Lung_Parenchyma-Control-Myeloid-TRAM-TRAM-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.89e-05 | 200 | 45 | 4 | ec39df7fb4454af629a4a4f6755bd02c9581a2ca | |
| ToppCell | Lung_Parenchyma-Control-Myeloid-TRAM|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.89e-05 | 200 | 45 | 4 | ecd2b9a7d464792b77381d0a0bc7030e77ad3581 | |
| ToppCell | severe-Myeloid-CD14_Monocytes_2|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.89e-05 | 200 | 45 | 4 | 27d51fefe914b90e0a16498c43607d52fd38f53c | |
| ToppCell | Parenchyma_Control_(B.)-Immune-TX-TRAM-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 4.89e-05 | 200 | 45 | 4 | b92804f15586e1802fdd931d6dfe742be8466944 | |
| ToppCell | Parenchyma_COVID-19-Immune-TX-MoAM-3|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 4.89e-05 | 200 | 45 | 4 | a0eb6e9e21930539b8939082c4097f6dfe8efa9b | |
| ToppCell | control-HLA-DR-_S100A+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.89e-05 | 200 | 45 | 4 | 107a0665fb20247511a430178effd7630a619488 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.89e-05 | 200 | 45 | 4 | 4b4df0fe47498310d94448b8a289e58e4f5b5aa8 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.89e-05 | 200 | 45 | 4 | e68010c805fe76606bc3254b55a90a9b25d21936 | |
| ToppCell | Lung_Parenchyma-Control-Myeloid-TRAM-TRAM|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.89e-05 | 200 | 45 | 4 | b303553aca8fc021f932b52e88e9ef270d5a4f03 | |
| ToppCell | TCGA-Endometrium-Primary_Tumor-Endometrial_Adenocarcinoma-Serous_adenocarcinoma-6|TCGA-Endometrium / Sample_Type by Project: Shred V9 | 2.92e-04 | 128 | 45 | 3 | f69f2a68cb2e272a9e239b4d247c537ae7abd8f0 | |
| ToppCell | COVID-19_Moderate-B_cell|COVID-19_Moderate / disease group, cell group and cell class | 3.96e-04 | 142 | 45 | 3 | 88bb8d9bca66131df4ee7021b88248e146aa7aa6 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 4.74e-04 | 151 | 45 | 3 | 999c11d19b61d6b130ad5e623afa83cbdfe13cdd | |
| ToppCell | normal_Lung-Myeloid_cells-Undetermined|normal_Lung / Location, Cell class and cell subclass | 4.74e-04 | 151 | 45 | 3 | 23b6cf9a36ad0e937f69c75921bddd305a9a526c | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_MHC-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.93e-04 | 153 | 45 | 3 | 099382241971412f84b6feefb897360a74a41143 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_naive-B_naive-5|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.02e-04 | 154 | 45 | 3 | 020697ae8463b18f9b4270c404f52ce4c0e90135 | |
| ToppCell | ICU-NoSEP-Lymphocyte-T_NK-dnT|ICU-NoSEP / Disease, Lineage and Cell Type | 5.31e-04 | 157 | 45 | 3 | c02500cf9255737c6229ec729803acd568485fb4 | |
| ToppCell | Mild-MAIT|Mild / Disease group and Cell class | 5.72e-04 | 161 | 45 | 3 | 0c1a04485708d5302600cdc2d7dac1cb76b4033a | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_INF-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.72e-04 | 161 | 45 | 3 | b2315c7d81addd5216bdfab7c3d32f785b9ab040 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_4|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.82e-04 | 162 | 45 | 3 | 7d43d59531cbefe3ac94953b7faf7156b2a31441 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Myeloid-Monocytic-Nonclassical_Monocyte|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.03e-04 | 164 | 45 | 3 | 17d5b8bb7c015cf9f0d6e578a0d212eada39cb93 | |
| ToppCell | Mild-MAIT|World / Disease group and Cell class | 6.03e-04 | 164 | 45 | 3 | 21dc02997dfae73cf70ce291661928526605dba1 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-Plasma_cells-IgM_plasma_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.14e-04 | 165 | 45 | 3 | 6e8370b8e747d8ef44a2413a993291a3cd83a77c | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.25e-04 | 166 | 45 | 3 | ce570b768988e30898cf0387c2aa99989631f13f | |
| ToppCell | BAL-Mild-Lymphocyte-B|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.58e-04 | 169 | 45 | 3 | 307571e57c3bfdf15f0fe1a8b36585e8e4f8a207 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_1_(HAND1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.58e-04 | 169 | 45 | 3 | 3f738fc56bbc70dc77c9ba41025631f8264cd2b3 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Myeloid-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.16e-04 | 174 | 45 | 3 | 3533a47885af453d97739e5576e989d93d31be32 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.16e-04 | 174 | 45 | 3 | b487c5c46f074a69b9526a2c72daf218f66aa44b | |
| ToppCell | facs-Skin-nan-24m-Epithelial-basal_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.28e-04 | 175 | 45 | 3 | 21542be95059983d2c8bdf01ec711fdbf1ec1f62 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_macrophage-stroma-monocytoid_macrophage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.52e-04 | 177 | 45 | 3 | 945b2d0723a0a35c767604ae607d2c2d53bf0c82 | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_macrophage-stroma-monocytoid_macrophage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.65e-04 | 178 | 45 | 3 | e44b0aa82890ae84fc4d1343f1c65ae2fda69a11 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_I-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.77e-04 | 179 | 45 | 3 | 3d3716078afdb9a89ddfadb3197cd1b52fa770be | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.90e-04 | 180 | 45 | 3 | e3877f6ef5f54ff689058b4c996ab1851822f871 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Monocytic-Nonclassical_Monocyte|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.28e-04 | 183 | 45 | 3 | 4cc0961a67de76b8d756cd9ffcaa98e3fe3c3a69 | |
| ToppCell | PBMC-Control-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.28e-04 | 183 | 45 | 3 | fcb0f755382d88fb207fc2322cd224c09c6e2ea6 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.28e-04 | 183 | 45 | 3 | 82fe14fc7039415de41bdfd615a1380bed99f560 | |
| ToppCell | PBMC-Control-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.28e-04 | 183 | 45 | 3 | 4763df29c888d47c22076803b054f06b4cc29368 | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-B-CD5+_CCL22-_mature_B|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 8.42e-04 | 184 | 45 | 3 | 18aa9c43b79d12c9e420dfd9822745c022be6789 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-Monocytes|normal_Lymph_Node / Location, Cell class and cell subclass | 8.42e-04 | 184 | 45 | 3 | 3cec28ff076fa53d034428de2bb1a237e0c1568c | |
| ToppCell | normal-na-Lymphocytic_T-T8_naive-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 8.42e-04 | 184 | 45 | 3 | 4a81190b36d197736663e6177d3b76c1cb6282d6 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.42e-04 | 184 | 45 | 3 | 94139bc2c880db3a791741ff7c5630cca52263a5 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar-Macro_c1-C1QC|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.55e-04 | 185 | 45 | 3 | 0e8064bb317f26959d3c59b4f73d0c455161ccd7 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c3-EREG|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.55e-04 | 185 | 45 | 3 | 7bff05d8d34616adbaa0ea0b69eb30aa906bb9f8 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-Myeloid-Monocytes|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.55e-04 | 185 | 45 | 3 | f8de11dd53b34d36368a2082f24ec1416cb7dbae | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_INF|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.68e-04 | 186 | 45 | 3 | e4de270d38bbed022f545bd0bbaa9599e707ec87 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic-B_cells-Immature_B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.68e-04 | 186 | 45 | 3 | 459a7e97bbac2b2cd253aa4ab38d0e4ae6191e8b | |
| ToppCell | 3'|World / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.68e-04 | 186 | 45 | 3 | e265aac37f33947ff6c83f23f8a2c63bbccd60af | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Dendritic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.68e-04 | 186 | 45 | 3 | 38f9f7d3b782978fd23b2a7fe565266285d39e44 | |
| ToppCell | 3'_v3-GI_small-bowel-Myeloid_Mac-Erythrophagocytic_macrophages|GI_small-bowel / Manually curated celltypes from each tissue | 8.68e-04 | 186 | 45 | 3 | a0cc925af97e47efd0c9bc17c37963e8ad4e5b35 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-T_lymphocytic-effector_CD4-positive,_alpha-beta_T_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.82e-04 | 187 | 45 | 3 | e61c1755531469dd3850c9740474b5ad4e0499c1 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-Myeloid-Macrophages|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.82e-04 | 187 | 45 | 3 | 00930e407beaa337f72533a69f32d150faad8b9a | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 8.82e-04 | 187 | 45 | 3 | 0099def970fbc828756fbf853eca2ce77b8cd342 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Pleural_Mac|metastatic_Lymph_Node / Location, Cell class and cell subclass | 8.82e-04 | 187 | 45 | 3 | 88fac9f23047892acccbcc355d02ff079596fedf | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_naive-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.82e-04 | 187 | 45 | 3 | 3b1439018e265a61d9599e307a202e3c2f60ed32 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_naive|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.82e-04 | 187 | 45 | 3 | e99bc27d212c74da37770297122a4b30445ccd0d | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-Mono|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.95e-04 | 188 | 45 | 3 | fbf176b48b89c234e4e1e64739afc836bed78a96 | |
| ToppCell | Children_(3_yrs)-Immune-T_lymphocyte-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.09e-04 | 189 | 45 | 3 | df30478b288084a1bd48f660409dcc784040897c | |
| ToppCell | ILEUM-non-inflamed-(1)_T_cell-(1)_CD8_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 9.09e-04 | 189 | 45 | 3 | 2c8a2fb76ea002bac554bc1c761ce960b5e116e1 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.09e-04 | 189 | 45 | 3 | 0a490730cdc912d5233de59057550de0e4065747 | |
| ToppCell | 368C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|368C / Donor, Lineage, Cell class and subclass (all cells) | 9.23e-04 | 190 | 45 | 3 | cbba3d94a4c3e0b0d14f3b7c60dba5d6e097c5e3 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-Myeloid-Macrophages|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.37e-04 | 191 | 45 | 3 | 94c7da03e5264f4d73bb507ce339a935d90279a0 | |
| ToppCell | NS-critical-d_0-4|critical / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.37e-04 | 191 | 45 | 3 | 769942a6a31c13c583dc38e8a762df2f5c06c2fb | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-cDC2-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.37e-04 | 191 | 45 | 3 | 7bad04f8afa949ea952c5c0d71eec43271ade680 | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-DN_to_DP_transition_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination__)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.37e-04 | 191 | 45 | 3 | 4bd9db45e7b5c0d04368e08c8199d390744aa317 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-B_cells-Immature_B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.37e-04 | 191 | 45 | 3 | 8c35fccc4617694eae1e55b1107841ffe7f1bac8 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.37e-04 | 191 | 45 | 3 | 79e7089022063c5f2b2f1b27658c62b741f3a037 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-Myeloid|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.37e-04 | 191 | 45 | 3 | 1e668d67bc254ea15518e2c7a029a61087609b7a | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.37e-04 | 191 | 45 | 3 | b5715eeb72a97b7bc87b83f6c289e225f58da842 | |
| ToppCell | ILEUM-inflamed-(1)_T_cell-(1)_Th17_Trm|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 9.51e-04 | 192 | 45 | 3 | 12f7ea575da5d650c740e6060f5dab0478e563dd | |
| ToppCell | Control-Lymphoid-T|World / Disease state, Lineage and Cell class | 9.51e-04 | 192 | 45 | 3 | 253cf4d2cf88ad8c45b73779336180840bef054b | |
| ToppCell | PBMC-Severe-cDC_0|Severe / Compartment, Disease Groups and Clusters | 9.51e-04 | 192 | 45 | 3 | 4f4774b925058191673b4ba4b4d05b8b37f61795 | |
| Disease | CCL4 measurement | 2.01e-04 | 20 | 31 | 2 | EFO_0004751 | |
| Disease | macrophage inflammatory protein 1b measurement | 3.92e-04 | 136 | 31 | 3 | EFO_0008219 | |
| Disease | corpus callosum posterior volume measurement | 1.37e-03 | 52 | 31 | 2 | EFO_0010298 | |
| Disease | monocyte measurement | 3.37e-03 | 82 | 31 | 2 | EFO_0803547 | |
| Disease | cortical thickness | 5.68e-03 | 1113 | 31 | 5 | EFO_0004840 | |
| Disease | Abortion, Tubal | 5.86e-03 | 109 | 31 | 2 | C0000822 | |
| Disease | Early Pregnancy Loss | 5.86e-03 | 109 | 31 | 2 | C3830362 | |
| Disease | Miscarriage | 5.86e-03 | 109 | 31 | 2 | C4552766 | |
| Disease | Spontaneous abortion | 5.86e-03 | 109 | 31 | 2 | C0000786 | |
| Disease | large artery stroke | 6.29e-03 | 113 | 31 | 2 | EFO_0005524 | |
| Disease | language measurement | 8.73e-03 | 134 | 31 | 2 | EFO_0007797 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IMNNTGEWIRQNGGW | 126 | Q16548 | |
| WQQGYGPQGMWVPAG | 226 | Q96EP5 | |
| PWFNGWGFNLPRGQS | 181 | Q15777 | |
| NTRQWWMPDTGGANI | 741 | Q14703 | |
| MWWGGRGQSFNIAPQ | 1 | A4FU01 | |
| GQALEWMGWITPFNG | 61 | A0A0A0MS14 | |
| WMGWMNPNSGNTGYA | 66 | P0DP01 | |
| QGAWMCGQAGWTPQE | 521 | A6NEF3 | |
| GQGLEWMGWINPGNG | 61 | P0DTW3 | |
| WMGWINPGNGSPSYA | 66 | P0DTW3 | |
| GQGLEWMGWINPNSG | 61 | P23083 | |
| WMGWINPNSGGTNYA | 66 | P23083 | |
| GQRLEWMGWINAGNG | 61 | A0A0C4DH29 | |
| GQGLEWMGWISAYNG | 61 | A0A0C4DH31 | |
| GQGLEWMGWINTNTG | 61 | A0A0J9YVY3 | |
| WMGWINTNTGNPTYA | 66 | A0A0J9YVY3 | |
| GGWNITGPWDQDNFM | 321 | P0DPD8 | |
| GMWGEQRGDPGWNGQ | 461 | Q8IWX8 | |
| RLGNGQFGEVWMGTW | 276 | P06241 | |
| QPMGGGWQQGGAYNW | 716 | O75061 | |
| GASWYNVPGGMQDWN | 736 | O75976 | |
| NSWGPQWGMNGYFLI | 301 | P09668 | |
| MPFLGQDWRSPGQNW | 1 | Q969P5 | |
| PGWANSSAGSGRIWM | 101 | Q86VB7 | |
| GWAMSAPGNAWFGQG | 146 | Q9UGM3 | |
| MQAPWAGNRGWAGTR | 1 | Q96GU1 | |
| MAWRGWAQRGWGCGQ | 1 | Q9H300 | |
| LWATQGNMGPAAFWL | 281 | Q16647 | |
| GGPQGSWRFLQWNSM | 441 | B9A6J9 | |
| GGPQGSWRFLQWNSM | 441 | A6NDS4 | |
| GGPQGSWRFLQWNSM | 441 | P0C7X1 | |
| TFIWGFQGGNTNWKP | 911 | Q9Y4E5 | |
| GGPQGSWRFLQWNSM | 441 | A6NER0 | |
| QATSSGGGWPMNVWL | 156 | Q8TB22 | |
| MAANWTLSWGQGGPC | 1 | A6NJL1 | |
| GAQGNWMWLGIASFG | 26 | Q9UBV4 | |
| GGPQGSWRFLQWNSM | 441 | A0A087X179 | |
| QGDSNFNRMWQPEWG | 81 | Q8TF01 | |
| GGPQGSWRFLQWNSM | 441 | A0A087WVF3 | |
| GGPQGSWRFLQWNSM | 441 | Q6DHY5 | |
| GGPQGSWRFLQWNSM | 441 | Q8IZP1 | |
| MACRQRGGSWSPSGW | 1 | Q05996 | |
| GGFSSWHMNNSNGNW | 211 | Q9H2Y7 | |
| GGPQGSWRFLQWNSM | 441 | A0A087X1G2 | |
| GGPQGSWRFLQWNSM | 441 | A0A087WXS9 | |
| GGPQGSWRFLQWNSM | 441 | Q6IPX1 | |
| RQPNQGWSSGKNGWG | 736 | Q9UPQ9 | |
| GSGMLQYLQSWFPGW | 426 | Q5THJ4 | |
| AGFDVWMGNSRGNTW | 111 | P38571 |